For example, ROS and oxidative DNA damage may have anticancer effects in gastric cancer cells because the antioxidant enzyme peroxiredoxin 2 (PRDX2) is suppressed or gastrokine 2 (GKN2) is overexpressed [6, 7]. This evidence concerns the gene PRDX2 and gastric cancer.